Search results
Albert Bourla (Greek: Άλμπερτ Μπουρλά; born () October 21, 1961) is an American-Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions.
As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, “Breakthroughs that change patients’ lives,” with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.
View Albert Bourla’s profile on LinkedIn, a professional community of 1 billion members. Albert Bourla leads Pfizer in its purpose, Breakthroughs that change patients’ lives…
- Pfizer
Apr 28, 2021 · Albert Bourla is ushering in a new era at Pfizer after leading a historic triumph with a COVID-19 vaccine. Andrew Dunn. Apr 28, 2021, 6:21 AM PDT. Albert Bourla, the CEO of Pfizer. Crystal...
The CEO of Pfizer on Developing a Vaccine in Record Time. Summary. On March 19, 2020, as Covid-19 swept across the world, Bourla challenged everyone at Pfizer and its partner BioNTech—a German ...
Albert Bourla, the CEO of Pfizer, shares his insights and updates on the COVID-19 vaccine, health care, and science on Twitter.
Oct 30, 2021 · Riding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead. BY Erika Fry. October 30, 2021, 5:00 AM PDT. Albert Bourla is on top of the world—and in...
Nov 9, 2021 · Albert Bourla became CEO of Pfizer in 2019 – the pinnacle of a career at Pfizer spanning more than two decades, multiple continents and several different business functions. When he took the helm of the global pharmaceutical company, he accelerated a transformation to become a more science-driven, innovative company.
May 2, 2024 · W hen Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. But COVID-19 delayed those plans when...
On January 19, 2022, The Genesis Prize Foundation announced Dr. Albert Bourla, Chairman and CEO of Pfizer, as the 2022 Genesis Prize Laureate. Dr. Bourla was recognized for his leadership, determination, and willingness to assume great risks in delivering a safe and effective COVID-19 vaccine in record time.
Related searches
